Strategy and Talent

Compensation committees create sophisticated executive pay warning systems then routinely ignore their signals, mimicking pilots who override stall alarms.

Ramraj Cotton's five-year IPO preparation focuses on systems and tech infrastructure over growth, creating unique governance planning challenges for extended ti

Natco Pharma's demerger approval highlights board decision-making timeline gaps and valuation disclosure issues in corporate restructuring schemes.

AM/NS India promotes CFO Harlalka to CEO role without apparent external search process, raising questions about board nomination committee approach.

Biocon appoints Shreehas Tambe as CEO amid biologics-generics integration. Analysis of board succession planning for complex pharmaceutical business combination